Dr. Amber Salter is an Associate Professor of Biostatistics at UT Southwestern. She graduated from the University of Alabama at Birmingham with a PhD in Biostatistics in 2015 and has a MPH in Epidemiology. She holds joint appointments in the Department of Population and Data Sciences and the Peter O’Donnell Jr. Brain Institute.

Dr. Salter’s research interest are in the design, analysis and interpretation of clinical trials and epidemiologic studies with a heavy focus in the area of Multiple Sclerosis (MS). She is also interested in the design and analysis of large complex databases and the issues and implications of their use in practice. She has been conducting research in the disease area of MS for over 10 years, specifically working with a disease registry, the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry, which collects self-report data from persons with MS semi-annually.


Association of patient-reported cognitive impairment with quality of life and employment in multiple sclerosis
Lancia S, Marrie RA, Cutter G, Fox RJ, Salter A Multiple Sclerosis and Related Disorders 2024 Jul 87
Social Cognitive Theory Variables as Correlates of Physical Activity Behavior Among Hispanics With Multiple Sclerosis
Silveira SL, Motl RW, Salter A, Marquez DX Archives of physical medicine and rehabilitation 2024 Jun 105 1083-1088
Focusing on neural mechanisms of exercise training benefits in multiple sclerosis
Sandroff BM, Motl RW, Salter A Multiple Sclerosis and Related Disorders 2024 Jun 86
Prevalence and Associated Clinical Characteristics of Walking-Related Motor, Cognitive, and Fatigability in Progressive Multiple Sclerosis: Baseline Results From the CogEx Study
Ramari C, D’hooge M, Dalgas U, Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter GR, DeLuca J, Farrell R, Filippi M, Freeman J, Inglese M, Meza C, Motl RW, Rocca MA, Sandroff BM, Salter A, Kos D, Feys P Neurorehabilitation and Neural Repair 2024 May 38 327-338
Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis
Wooliscroft L, Salter A, Adusumilli G, Levasseur VA, Sun P, Lancia S, Perantie DC, Trinkaus K, Naismith RT, Song SK, Cross AH Multiple Sclerosis and Related Disorders 2024 Apr 84
Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials
Marrie RA, Salter A Neurology 2024 Mar 102 e208099
Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations
Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA Neurology 2024 Mar 102 e209135
Increased healthcare utilization in the year before multiple sclerosis diagnosis
Razzak AN, Hernandez RS, Salter A, Obeidat AZ Multiple Sclerosis and Related Disorders 2024 Mar 83
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force
Parciak T, Geys L, Helme A, van der Mei I, Hillert J, Schmidt H, Salter A, Zakaria M, Middleton R, Stahmann A, Dobay P, Hernandez Martinez-Lapiscina E, Iaffaldano P, Plueschke K, Rojas JI, Sabidó M, Magyari M, van der Walt A, Arickx F, Comi G, Peeters LM Multiple Sclerosis Journal 2024 Mar 30 396-418
Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)
Vernino S, Hopkins S, Bryarly M, Hernandez RS, Salter A Clinical Autonomic Research 2024 Feb 34 153-163